HITI vs. GLSI, GNFT, CGEN, TELO, ACET, IVA, GOSS, SKYE, SCPH, and CADL
Should you be buying High Tide stock or one of its competitors? The main competitors of High Tide include Greenwich LifeSciences (GLSI), Genfit (GNFT), Compugen (CGEN), Telomir Pharmaceuticals (TELO), Adicet Bio (ACET), Inventiva (IVA), Gossamer Bio (GOSS), Skye Bioscience (SKYE), scPharmaceuticals (SCPH), and Candel Therapeutics (CADL). These companies are all part of the "medical" sector.
Greenwich LifeSciences (NASDAQ:GLSI) and High Tide (NASDAQ:HITI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking.
High Tide received 4 more outperform votes than Greenwich LifeSciences when rated by MarketBeat users. Likewise, 39.13% of users gave High Tide an outperform vote while only 33.33% of users gave Greenwich LifeSciences an outperform vote.
Greenwich LifeSciences has higher earnings, but lower revenue than High Tide. Greenwich LifeSciences is trading at a lower price-to-earnings ratio than High Tide, indicating that it is currently the more affordable of the two stocks.
Greenwich LifeSciences presently has a consensus price target of $36.00, indicating a potential upside of 197.52%. High Tide has a consensus price target of $4.50, indicating a potential upside of 122.77%. Given High Tide's higher possible upside, research analysts plainly believe Greenwich LifeSciences is more favorable than High Tide.
In the previous week, Greenwich LifeSciences and Greenwich LifeSciences both had 2 articles in the media. High Tide's average media sentiment score of 1.05 beat Greenwich LifeSciences' score of 0.75 indicating that Greenwich LifeSciences is being referred to more favorably in the media.
4.2% of Greenwich LifeSciences shares are held by institutional investors. Comparatively, 4.5% of High Tide shares are held by institutional investors. 52.9% of Greenwich LifeSciences shares are held by company insiders. Comparatively, 12.4% of High Tide shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Greenwich LifeSciences has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, High Tide has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.
Greenwich LifeSciences has a net margin of 0.00% compared to Greenwich LifeSciences' net margin of -7.46%. Greenwich LifeSciences' return on equity of -2.03% beat High Tide's return on equity.
Summary
High Tide beats Greenwich LifeSciences on 9 of the 15 factors compared between the two stocks.
Get High Tide News Delivered to You Automatically
Sign up to receive the latest news and ratings for HITI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HITI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
High Tide Competitors List
Related Companies and Tools
